Agronomic portal Agronom.info
Categories
Language
Currency
My account
Soybean

SK AVA

Seeds: protein content
41-43%
Diseases
Rot
Country
Russia
Registration Year
2023
No active offers.
Views
15
Reviews
0
Producer
LLC COMPANY 'SOEVY COMPLEX'
Manufacturer
LLC COMPANY 'SOEVY COMPLEX'
Description SK AVA
SK AVA is an ultra-early soybean (Glycine max) variety characterized by a short vegetative period and reliable maturity across all permitted regions. This variety exhibits high plasticity to various soil and climate conditions and cultivation technologies, making it universal for growing in the Central, North Caucasian, Middle Volga, and Ural regions. Thanks to its resistance to lodging and ability to withstand prolonged standing for over two weeks, SK AVA ensures a stable yield even under complex conditions.

One of the key features of the variety is the increased protein content in seeds — more than 40%, specifically 42-44%, which is significantly higher than the average. Additionally, seeds contain 19-21% fat, making this variety particularly valuable for the production of protein products and feeds. The mass of 1000 seeds varies from 160 to 175 grams, indicating the size and quality of the seed material. The variety also exhibits high resistance to powdery mildew, which reduces the risk of yield loss and increases its processability.

SK AVA belongs to the indeterminate type, ensuring its flexibility and adaptability in various agro-technical conditions. High yield combined with an improved qualitative composition of seeds makes this variety attractive for agricultural producers focused on obtaining high-protein products. Thanks to its characteristics, SK AVA is a promising choice for efficient and sustainable soybean cultivation in diverse regions.
Specifications SK AVA
Diseases
Rot
Rots
Seeds: protein content
41-43%
Country
Russia
Registration Year
2023
Catalog
Varieties
Technical Crops
Manufacturer
LLC COMPANY 'SOEVY COMPLEX'
Where to buy SK AVA
Loading...
Reviews SK AVA
0comments
Sort by:Popular first
No comments yet.